New vaccine trial offers hope for cancer patients
Johns Hopkins researchers found a personalized melanoma vaccine improves patient outcomes in a major new clinical trial study.
Mark Yarchoan said vaccines are transformative advances in medicine. He said direct targeting of established cancers had largely failed until now in his editorial published recently in the journal New England Journal of Medicine.
Elizabeth Jaffee helped create a hopeful plan to fight disease with shots. She explained that scientists believed they could train the immune system to find cancer but lacked the necessary tools to make this work in patients effectively.
Early vaccines combined with checkpoint immunotherapy help release brakes on the immune system. This process creates specific groups of fighting cells inside pancreatic tumors which were long considered hardest for the body to attack successfully.
Personalized vaccines identify distinctive mutations in a patient tumor to stimulate T cells. They apply blocking therapy to help those immune cells stay active against the disease progression over time effectively for better results.
“Vaccines have been among the most transformative advances in modern medicine”

